欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0426/001
药品名称
Oraqix periodontal gel
活性成分
lidocaine 25.0 mg/g
prilocaine 25.0 mg/g
剂型
[not specified]
上市许可持有人
Dentsply DeTrey GmbH Germany
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
France (FR)
Italy (IT)
Norway (NO)
Finland (FI)
Spain (ES)
Germany (DE)
Oraqix Periodontal Gel
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
许可日期
2004/07/16
最近更新日期
2022/12/05
药物ATC编码
N01BB20 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0426/001_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0426/001_Final SPC
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase